NCT05069350View on ClinicalTrials.gov

Bupivacaine vs Oxybuprocaine Topical Anesthesia in IVI

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 1, 2021

Primary Completion Date

August 1, 2022

Study Completion Date

August 1, 2022

Conditions
Pain, Acute
Interventions
DRUG

bupivacaine 0.5% and oxubuprocaine

using each drug as surface anesthesia before intravitreal injections

Trial Locations (1)

12513

Research Institute of Ophthamology, Giza

All Listed Sponsors
lead

Research Institute of Ophthalmology, Egypt

OTHER